Where Science Meets HOPE
HOPE-Neuron Therapeutx is a neurobiology company developing SELanetx™, a novel therapeutic platform designed to treat ALS and related autoimmune neurodegenerative disorders. By harnessing mechanotransduction and controlled hyperoxia, we trigger a natural apoptotic process that reprograms the immune system—without drugs or stem cells.
Backed by published research, leading clinical partnerships, and a growing global IP portfolio, we aim to bring disruptive, scalable healing to patients with ALS, MS, Parkinson’s, and eventually Alzheimer’s.
Device enhanced Hyperoxia Generated Apoptotic Activation
Whole blood Apoptotic Activation via Precision Cellular Control
Apoptosis Signals “Efferocytosis” and the M1-M2 Immune Cell-Shift
Sterile 30-minute Closed-Loop, 300~ml IV, Withdrawal & Re-Infusion
“It works”, p<0.008, M1-M2 Cell-Shift impacting disease, delivers HOPE
SELanetx™: Precision Apoptogenics
Proof of Concept:
From Treadmill to Clinic
Beyond ALS: A Treatment for Autoimmune-Neurodegenerative Diseases
The mechanism behind SELanetx™ is broadly applicable across neuroinflammatory diseases. Following ALS, we plan to extend validation and human IRB trials into:
Problem
Multiple Sclerosis (MS)
Problem
Parkinson’s Disease (PD)
Problem
Alzheimer’s Disease (AD)
By rebalancing the immune system through natural apoptotic pathways, we aim to transform the treatment of chronic neurodegeneration.
Learn More About Our Therapy